Evidence map›Paper›PMID 40148342›Full record

ReviewNature reviews. Disease primers2025

Achilles tendinopathy.

Andreas Traweger, Alex Scott, Michael Kjaer, Evi Wezenbeek, Rodrigo Scattone Silva, John G Kennedy, James J Butler, Manuel Gomez-Florit, Manuela E Gomes, Jess G Snedeker and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Engineered NestinJournal of extracellular vesicles · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cyclic mechanical stimulation of TDCs improves tendon tissue maturationFrontiers in bioengineering and biotechnology · 2026
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andreas TrawegerInstitute of Tendon and Bone Regeneration, Paracelsus Medical University, Salzburg, Austria. andreas.traweger@pmu.ac.at.ORCID http://orcid.org/0000-0002-0220-4766
Alex ScottDepartment of Physical Therapy, Centre for Aging SMART, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0003-0366-8404
Michael KjaerInstitute of Sports Medicine Copenhagen, Department of Orthopedic Surgery M, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Evi WezenbeekMOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy (REVAKI), University of Antwerp, Wilrijk, Belgium.ORCID http://orcid.org/0000-0001-9303-6915
Rodrigo Scattone SilvaHealth Sciences College of Trairi, Federal University of Rio Grande do Norte, Santa Cruz, Brazil.ORCID http://orcid.org/0000-0002-7973-188X
John G KennedyNYU Langone Health, NYU Langone Orthopedic Hospital, New York, NY, USA.
James J ButlerNYU Langone Health, NYU Langone Orthopedic Hospital, New York, NY, USA.
Manuel Gomez-FloritHealth Research Institute of the Balearic Islands (IdISBa), Research Unit Son Espases University Hospital (HUSE), Palma, Spain.ORCID http://orcid.org/0000-0001-7758-1251
Manuela E GomesSchool of Medicine and Biomedical Sciences (ICBAS), Unit for Multidisciplinary Research in Biomedicine (UMIB), University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0002-2036-6291
Jess G SnedekerDepartment of Orthopaedics, Balgrist, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8115-0275
Stephanie G DakinNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2470-1031
Britt WildemannExperimental Trauma Surgery, Department of Trauma, Hand and Reconstructive Surgery, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany. britt.wildemann@med.uni-jena.de.ORCID http://orcid.org/0000-0002-8365-1188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achilles tendon pathologies are prevalent, impacting ~6% of the general population and up to 50% of elite endurance runners over their lifetimes. These conditions substantially affect quality of life and work productivity, leading to substantial societal costs. Achilles tendinopathy (AT) is a condition marked by localized pain and functional impairment related to mechanical loading. AT can considerably impair participation and potentially also performance in sports and daily activities. The aetiology of AT is multifactorial and repetitive overloading of the tendon is often observed as the inciting factor by health professionals. However, AT can also be associated with adverse effects of certain medication, ageing and various comorbidities. Characteristic tendon changes include proteoglycan accumulation, fluid accumulation with swelling and hypervascularization. Tissue disorganization advances as pathological changes in matrix structure are driven by altered cellular function and makeup, often accompanied by persistent inflammation. Treatment strategies include various interventions, although these can be protracted and challenging for both patients and health-care providers, often with high failure rates. Current research focuses on understanding the pathological processes at the cellular and molecular levels to distinguish between disease categories and to investigate the role of inflammation, metabolic maladaptation and mechanical stress. Emerging therapeutic approaches need to be developed to address these underlying mechanisms. These approaches focus on optimizing rehabilitation protocols and advancing the development of adjunct therapies, such as advanced therapy medicinal products, alongside the integration of precision medicine to improve treatment outcomes.

Indexed as

Achilles TendonTendinopathyHumansQuality of Life

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.